EUVIMEDEUVIMED entdecken
Netzwerk-MetaanalyseSystematische Übersicht

Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis

Damian Swieczkowski iD, Aleksander Kwaśny, Michal Pruc, Zuzanna Gaca, Lukasz Szarpak, Wiesław J Cubała

The International Journal of Psychiatry in Medicine · 2025

DOI: 10.1177/00912174251337572 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift The International Journal of Psychiatry in Medicine, 2025. Verfasst von Damian Swieczkowski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland. Hauptthemen laut MEDLINE: Anxiety, Depression, Hallucinogens, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate psilocybin's efficacy in reducing depressive and anxiety symptoms in cancer patients based on randomized controlled trials (RCTs).

Methods

This systematic review and network meta-analysis (NMA) followed PRISMA and Cochrane Handbook guidelines. PubMed, Embase and Cochrane Library data up to July 2024 were analyzed. Two RCTs met the inclusion criteria. Changes in Beck Depression Inventory (BDI) and State-Trait Anxiety Inventory (STAI) scores were assessed on day 1 and on 2-week follow-up. The risk of bias was evaluated with the Cochrane Risk of Bias Tool 2.0.

Results

Psilocybin significantly reduced BDI scores at day 1 post-administration (MD = 2.26; P = 0.01), though effects were not sustained at 2 weeks. STAI state scores showed substantial reductions at both day 1 (MD = 11.52; P < 0.001) and 2 weeks (MD = 12.66; P < 0.001). STAI trait scores also improved on both day 1 and day 14. The highest psilocybin dose (0.3 mg/kg) was the most effective, with SUCRA values of 87.81% (BDI), 91.58% (STAI state), and 94.2% (STAI trait).

Conclusions

Findings suggest psilocybin may rapidly reduce depressive and anxiety symptoms in cancer patients, but methodological limitations, including the small number of trials, necessitate cautious interpretation. Larger, high-quality RCTs are needed to verify its clinical potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnxietyDepressionHallucinogensNeoplasmsOutcome Assessment, Health CarePsilocybinPsychotherapyHumansRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

anxietycancermajor depressive disorderpalliative medicinepalliative psychiatrypsilocybinrapid-acting antidepressants

Substanzen

HallucinogensPsilocybin

Autor:innen und Institutionen

  • Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland.
  • Department of Toxicology, Faculty of Pharmacy, Medical University of Gdansk, Gdansk, Poland.
  • Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
  • Department of Public Health, International European University, Kyiv, Ukraine.
  • Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Research Unit, Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland.

ORCID-Profile: Damian Swieczkowski

Zitieren

APA

Swieczkowski, D., Kwaśny, A., Pruc, M., Gaca, Z., Szarpak, L., & Cubała, W. J. (2025). Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis. The International Journal of Psychiatry in Medicine. https://doi.org/10.1177/00912174251337572

Vancouver

Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ. Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis. The International Journal of Psychiatry in Medicine. 2025. doi:10.1177/00912174251337572

BibTeX
@article{Swieczkowski2025,
  author = {Swieczkowski, Damian and Kwaśny, Aleksander and Pruc, Michal and Gaca, Zuzanna and Szarpak, Lukasz and Cubała, Wiesław J},
  title = {Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis},
  journal = {The International Journal of Psychiatry in Medicine},
  year = {2025},
  doi = {10.1177/00912174251337572}
}
Kostenlos starten →